Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend) |
Evidence[PMID] |
TSPO |
translocator protein (18kDa) |
22q13.3 |
3(1/2/0)
|
IEA
|
ANXA1 |
annexin A1 |
9q21.13 |
1(0/0/1)
|
IEA
|
IL6 |
interleukin 6 |
7p21-p15 |
1(0/1/0)
|
IEA
|
HTR6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
1p36-p35 |
3(1/2/0)
|
IEA
|
DUSP6 |
dual specificity phosphatase 6 |
12q22-q23 |
5(3/2/0)
|
IEA
|
SNCG |
synuclein, gamma (breast cancer-specific protein 1) |
10q23.2-q23.3 |
1(0/1/0)
|
IEA
|
GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
16p13.2 |
1(1/0/0)
|
IEA
|
GAD1 |
glutamate decarboxylase 1 (brain, 67kDa) |
2q31 |
2(1/1/0)
|
IEA
|
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
17q |
1(0/1/0)
|
IEA
|
IFNG |
interferon, gamma |
12q14 |
2(2/0/0)
|
IEA
|
HTR2C |
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
Xq23 |
7(4/3/0)
|
IDA[18703043]
|
SOD2 |
superoxide dismutase 2, mitochondrial |
6q25 |
2(1/1/0)
|
IEA
|
MTHFR |
methylenetetrahydrofolate reductase (NAD(P)H) |
1p36.3 |
16(10/6/0)
|
IEA
|
MAOB |
monoamine oxidase B |
Xp11.4-p11.3 |
4(2/2/0)
|
IEA
|
GABRG3 |
gamma-aminobutyric acid (GABA) A receptor, gamma 3 |
15q12 |
1(0/1/0)
|
IEA
|
CREB1 |
cAMP responsive element binding protein 1 |
2q34 |
2(1/1/0)
|
IEA
|
P2RX7 |
purinergic receptor P2X, ligand gated ion channel, 7 |
12q24 |
9(2/7/0)
|
IEA
|
TFAP2B |
transcription factor AP-2 beta (activating enhancer binding protein 2 beta) |
6p12 |
1(0/1/0)
|
IEA
|
GSK3B |
glycogen synthase kinase 3 beta |
3q13.3 |
8(0/8/0)
|
IEA
|
GCLM |
glutamate-cysteine ligase, modifier subunit |
1p21 |
1(0/0/1)
|
IDA[9895302]
|
XBP1 |
X-box binding protein 1 |
22q12.1 |
3(2/1/0)
|
IEA
|
NNMT |
nicotinamide N-methyltransferase |
11q23.1 |
1(1/0/0)
|
IEA
|
FABP3 |
fatty acid binding protein 3, muscle and heart |
1p33-p32 |
2(1/1/0)
|
IEA
|
NGF |
nerve growth factor (beta polypeptide) |
1p13.1 |
2(1/1/0)
|
IEA
|
ABCB1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
7q21.12 |
1(1/0/0)
|
TAS[3022150]
|
CRH |
corticotropin releasing hormone |
8q13 |
2(1/1/0)
|
IEA
|
DRD2 |
dopamine receptor D2 |
11q22-q23 |
28(8/20/0)
|
ISS
|
ATP1A3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
19q13.2 |
3(2/1/0)
|
IEA
|
SRD5A2 |
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
2p23.1 |
1(0/1/0)
|
IEA
|
DRD3 |
dopamine receptor D3 |
3q13.3 |
19(4/15/0)
|
ISS
|
LRP8 |
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
1p32.3 |
1(1/0/0)
|
IEA
|
SLC6A2 |
solute carrier family 6 (neurotransmitter transporter), member 2 |
16q12.2 |
2(0/2/0)
|
IEA
|
IL10 |
interleukin 10 |
1q31-q32 |
1(0/1/0)
|
IEA
|
DPYSL2 |
dihydropyrimidinase-like 2 |
8p22-p21 |
2(1/0/1)
|
IEA
|
FYN |
FYN proto-oncogene, Src family tyrosine kinase |
6q21 |
1(1/0/0)
|
IEA
|
HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
13q14-q21 |
22(7/15/0)
|
IDA[15862800]
|
APOD |
apolipoprotein D |
3q29 |
1(0/1/0)
|
ISS
|
ADRA1A |
adrenoceptor alpha 1A |
8p21.2 |
2(0/2/0)
|
ISS
|
COMT |
catechol-O-methyltransferase |
22q11.21 |
28(14/14/0)
|
IEA
|
DRD1 |
dopamine receptor D1 |
5q34-q35 |
11(6/5/0)
|
ISS
|
SRR |
serine racemase |
17p13 |
1(0/1/0)
|
IEA
|
IL1RN |
interleukin 1 receptor antagonist |
2q14.2 |
2(2/0/0)
|
IEA
|
TNF |
tumor necrosis factor |
6p21.3 |
4(2/2/0)
|
IEA
|
GAD2 |
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) |
10p13-p11.2 |
1(0/1/0)
|
IEA
|
BCL2 |
B-cell CLL/lymphoma 2 |
18q21.3 |
2(0/2/0)
|
IDA[36599]; IMP[17875758]
|
OXTR |
oxytocin receptor |
3p25 |
1(0/1/0)
|
IEA
|
BDH1 |
3-hydroxybutyrate dehydrogenase, type 1 |
3q29 |
2(1/1/0)
|
IEA
|
SST |
somatostatin |
3q28 |
1(0/1/0)
|
IEA
|
DAB1 |
Dab, reelin signal transducer, homolog 1 (Drosophila) |
1p32-p31 |
1(0/1/0)
|
IEA
|
ATP1A1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
1p13 |
1(1/0/0)
|
IEA
|
OXCT1 |
3-oxoacid CoA transferase 1 |
5p13 |
1(1/0/0)
|
IEA
|
CPB2 |
carboxypeptidase B2 (plasma) |
13q14.11 |
1(1/0/0)
|
IEA
|
SLC6A4 |
solute carrier family 6 (neurotransmitter transporter), member 4 |
17q11.2 |
44(18/26/0)
|
IEA
|
SLC1A2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
11p13-p12 |
1(1/0/0)
|
IEA
|
GNAS |
GNAS complex locus |
20q13.2-q13.3 |
1(0/1/0)
|
IEA
|
SLC6A3 |
solute carrier family 6 (neurotransmitter transporter), member 3 |
5p15.3 |
11(5/6/0)
|
IEA
|
GNA12 |
guanine nucleotide binding protein (G protein) alpha 12 |
7p22.3 |
1(1/0/0)
|
IEA
|